CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Biomarker
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
    Technologies and Software
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Cell and Gene Therapy

Top Cell Encapsulation System Manufacturers 2026

Cell encapsulation system manufacturers develop equipment used to enclose biological cells within protective materials for research and therapeutic applications. With a focus on encapsulation precision, cell viability, process consistency and system compatibility, they support advanced biotechnology research and more reliable cell-based applications.

Solutions
TheraCyte: Advancing Cell Therapy through Engineered Cell Encapsulation
TheraCyte
Advancing Cell Therapy through Engineered Cell Encapsulation
Paul Quadros, Chairman
Turning engineered cells into viable treatments requires more than developing cells with a desired function. Once implanted, those cells must survive the body’s immune response while receiving nutrients and releasing therapeutic molecules. TheraCyte’s encapsulation technology was developed at Baxter Healthcare Corporation over roughly a decade, with approximately $30 million invested in its development. Since becoming an independent company in 1999, TheraCyte has focused on supplying the technology to outside researchers, allowing scientists to investigate cell-based therapies without developing their own encapsulation devices.
Read more
State of Industry

Advanced Encapsulation Systems: Supporting Consistent Cell Processing

Cell encapsulation technology is expanding the opportunities to develop and deliver next-generation therapies. It isolates living cells in a protective material, creating a controlled environment while allowing the passage of certain materials between the cells and the surrounding tissue. Examples of applications are regenerative medicine, tissue engineering and cell-based therapies. A manufacturer of cell encapsulation systems creates and produces equipment that makes it much simpler for controlled processing, consistent material handling and protection of sensitive cells.

Read more
Deep Dive

Cell Encapsulation Systems Require More than Immune Protection

Cell therapies can appear promising in laboratory assays yet become difficult to assess after implantation. An early immune response may destroy transplanted cells before researchers can determine whether they produce the intended therapeutic substance. Encapsulation systems address that interference, but preventing immune attack is only part of the purchase decision. A barrier that also restricts nutrient delivery or the release of therapeutic molecules can defeat the purpose of protecting the cells. The device must support a credible experiment, not merely keep its contents separated from surrounding tissue. 

Read more
Leadership Perspective
Cellular Therapy: Recommendations for Developing a Cell Therapy Program
University of Pennsylvania Health System
Cellular Therapy: Recommendations for Developing a Cell Therapy Program
Robert Richards, Corporate Director of The Center for Cell Therapy and Transplant, Penn Medicine

Cellular therapy treatment has been around for 50 years, getting its start with hematopoietic stem cell transplant bone marrow transplant (HSCT) as the treatment of blood cancers. In 2017, a new type of treatment called Chimeric Antigen Receptor T-cell (CAR-T) therapy, has been effective for many patients with far advanced relapsed and refractory blood cancers, and may be used increasingly in the future to supplant BMT. CAR-T uses a patient’s reengineered T-cells to seek and destroy cancer cells in the patient’s body. UPHS, like many other established BMT centers, had to prepare by building the infrastructure to onboard these therapies.  Development of a CAR-T therapy infrastructure has created issues that were unique from BMT, including the high dollar cost of the therapy that puts increased risk on centers when delivering this care to patients.

Read more

Cell Encapsulation System Manufacturers Info

Q1
What Do Top Cell Encapsulation Systems Manufacturers Provide?
Top Cell Encapsulation Systems Manufacturers develop devices and platforms that enclose living cells within protective, selectively permeable barriers. These systems are designed to limit direct immune contact while allowing oxygen, nutrients and cell-produced therapeutic molecules to move across the membrane. Depending on the research or intended application, products may differ in membrane composition, capsule or chamber design, cell capacity, implantation format and the degree of customization available.
Q2
Which Manufacturer Did Life Sciences Review Recognize for Cell Encapsulation Systems in 2026?
Life Sciences Review recognized TheraCyte as its Top Cell Encapsulation Systems Manufacturer for 2026. The company supplies encapsulation devices to academic laboratories and pharmaceutical organizations studying engineered cell therapies, rather than developing proprietary cell treatments of its own. Its platform gives research teams access to a protective device for investigating different cell types and therapeutic applications without first having to design and build an encapsulation system themselves.
Q3
Why Is Demand for Cell Encapsulation Systems Growing?
Interest in cell-based treatments is encouraging research into ways of keeping implanted cells functional while managing the recipient’s immune response. Top Cell Encapsulation Systems Manufacturers serve this need by developing barriers that support the exchange of nutrients and therapeutic substances while limiting immune-cell contact. Research into diabetes and other conditions, alongside wider exploration of engineered cells, is creating varied experimental requirements for devices that can support preclinical investigation and future therapeutic development.
Q4
What Should Research Teams Evaluate When Choosing Cell Encapsulation Systems?
When comparing options, research teams should assess membrane biocompatibility, permeability, cell viability and the ability to maintain the required exchange of oxygen, nutrients and therapeutic products. Top Cell Encapsulation Systems Manufacturers should also be evaluated on device consistency, capacity, configuration options, implantation method and compatibility with the intended cell type and study model. For translational work, teams should clarify manufacturing controls, documentation and the regulatory pathway relevant to the proposed use.
Q5
How Are Technology and Expertise Advancing Cell Encapsulation Systems?
Progress depends on balancing immune protection with the movement of substances needed to sustain cell activity. Top Cell Encapsulation Systems Manufacturers work across membrane materials, device architecture and fabrication methods to address that challenge. Design considerations include diffusion, mechanical stability, cell loading and maintaining consistent conditions after implantation. Advances in material characterization and manufacturing controls can help researchers assess whether a system performs reliably across studies and can be adapted to different cell types.
Q6
What Documented Capabilities Support TheraCyte’s Recognition?
TheraCyte’s platform uses layered biocompatible membranes to shield enclosed cells from immune response while allowing nutrients and therapeutic molecules to pass through. Its devices have featured in hundreds of animal studies and peer-reviewed research. The technology was also investigated in two earlier human clinical trials involving about 50 people. The company offers configurations with internal channels and subchambers. This places TheraCyte among the Top Cell Encapsulation Systems Manufacturers; its current devices are supplied for research use.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/a/cell-encapsulation-system-manufacturers